NCT06515366 MAP( Mean Arterial Pressure) and Mortality Relation in Patients With Heart Failure
| NCT ID | NCT06515366 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Saglik Bilimleri Universitesi |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 280 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 280 participants in total. It began in 2024-06-01 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aim of this observational study is to evaluate the relationship between mean arterial pressure (MAP) and mortality in patients presenting to the emergency department with acute heart failure, focusing on emergency department monitoring and subgroup presentations. Our goal is to determine the impact of subgroup characteristics on mortality among patients presenting with heart failure in the emergency department, and to assess the predictive value and significance of MAP in predicting mortality.
Eligibility Criteria
Inclusion Criteria: Age 18 and above Patients presenting with symptoms of heart failure Exclusion Criteria: Age under 18 Patients presenting with ST-elevation myocardial infarction Patients with acute kidney failure Pregnant patients Patients with inaccessible data for the parameters under study
Contact & Investigator
gulsen akcay, ass. prof.
STUDY DIRECTOR
ass. prof. of organization
Frequently Asked Questions
Who can join the NCT06515366 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06515366 currently recruiting?
Yes, NCT06515366 is actively recruiting participants. Contact the research team at gulakcay@yahoo.com.tr for enrollment information.
Where is the NCT06515366 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06515366 clinical trial?
NCT06515366 is sponsored by Saglik Bilimleri Universitesi. The principal investigator is gulsen akcay, ass. prof. at ass. prof. of organization. The trial plans to enroll 280 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.